Extended interval dosing with ocrelizumab in multiple sclerosis. Novak F, Bajwa HM, Ostergaard K, Berg JM, et al. Mult Scler 2024 Apr 22:13524585241245296. doi: 10.1177/13524585241245296.

Read + Share

Amedeo Smart

Independent Medical Education

Novak F, Bajwa HM, Ostergaard K, Berg JM, et al. Extended interval dosing with ocrelizumab in multiple sclerosis. Mult Scler 2024 Apr 22:13524585241245296. doi: 10.1177/13524585241245296.
PMID: 38646949